Device Trial Radar · NCT03865979
AI ENRICH - AI Detection of ICH
Last checked: Nov 20, 2026Latest source record: Sep 19, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
10
Actual
Start
Jan 23, 2020
Primary completion
Mar 15, 2023
Study completion Apr 28, 2023
Sponsor
- Lead sponsor
- Viz.ai, Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Nico Corporation
- First posted
- Mar 7, 2019
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Health services research
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the performance of the Viz RECRUIT software in subjects identified as symptomatic of a stroke event as determined by standard of care imaging assessments and interpretation.
Conditions
- Intracerebral Hemorrhage
Interventions
Viz RECRUITDevice
Viz RECRUIT includes the following modules: Viz ICH, Viz VOLUME, Viz VIEW and Viz HUB
Primary outcomes
What the sponsor says the trial is designed to measure.
- PerformanceTime frame: Enrollment
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
UAMS Medical Center
Little Rock, Arkansas
Northshore University Health System
Evanston, Illinois
Cooper University Hospital
Camden, New Jersey
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.